Literature DB >> 16177361

Effect of deletion or overexpression of the 19-kilodalton lipoprotein Rv3763 on the innate response to Mycobacterium tuberculosis.

Graham R Stewart1, Katalin A Wilkinson, Sandra M Newton, Susan M Sullivan, Olivier Neyrolles, John R Wain, Janisha Patel, Kara-Lee Pool, Douglas B Young, Robert J Wilkinson.   

Abstract

The 19-kDa lipoprotein of Mycobacterium tuberculosis is an important target of the innate immune response. To investigate the immune biology of this antigen in the context of the whole bacillus, we derived a recombinant M. tuberculosis H37Rv that lacked the 19-kDa-lipoprotein gene (Delta19) and complemented this strain by reintroduction of the 19-kDa-lipoprotein gene on a multicopy vector to produce Delta19::pSMT181. The Delta19 strain multiplied less well than Delta19::pSMT181 in human monocyte-derived macrophages (MDM) (P = 0.039). Surface expression of major histocompatibility complex class II molecules was reduced in phagocytes infected with M. tuberculosis; this effect was not seen in cells infected with Delta19. Delta19 induced lower interleukin 1beta (IL-1beta) secretion from monocytes and MDM. Overexpression of the 19-kDa protein increased IL-1beta, IL-12p40, and tumor necrosis factor alpha secretion irrespective of phagocyte maturity. These data support reports that the 19-kDa lipoprotein has pleiotropic effects on the interaction of M. tuberculosis with phagocytes. However, this analysis indicates that in the context of the whole bacillus, the 19-kDa lipoprotein is only one of a number of molecules that mediate the innate response to M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177361      PMCID: PMC1230982          DOI: 10.1128/IAI.73.10.6831-6837.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria.

Authors:  O Neyrolles; K Gould; M P Gares; S Brett; R Janssen; P O'Gaora; J L Herrmann; M C Prévost; E Perret; J E Thole; D Young
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

2.  Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.

Authors:  H D Brightbill; D H Libraty; S R Krutzik; R B Yang; J T Belisle; J R Bleharski; M Maitland; M V Norgard; S E Plevy; S T Smale; P J Brennan; B R Bloom; P J Godowski; R L Modlin
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

Review 3.  Pattern recognition receptors: doubling up for the innate immune response.

Authors:  Siamon Gordon
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

4.  Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.

Authors:  E H Noss; R K Pai; T J Sellati; J D Radolf; J Belisle; D T Golenbock; W H Boom; C V Harding
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

5.  An increase in expression of a Mycobacterium tuberculosis mycolyl transferase gene (fbpB) occurs early after infection of human monocytes.

Authors:  R J Wilkinson; L E DesJardin; N Islam; B M Gibson; R A Kanost; K A Wilkinson; D Poelman; K D Eisenach; Z Toossi
Journal:  Mol Microbiol       Date:  2001-02       Impact factor: 3.501

6.  Induction of direct antimicrobial activity through mammalian toll-like receptors.

Authors:  S Thoma-Uszynski; S Stenger; O Takeuchi; M T Ochoa; M Engele; P A Sieling; P F Barnes; M Rollinghoff; P L Bolcskei; M Wagner; S Akira; M V Norgard; J T Belisle; P J Godowski; B R Bloom; R L Modlin
Journal:  Science       Date:  2001-02-23       Impact factor: 47.728

7.  The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2.

Authors:  Martín López; Laura M Sly; Yvonne Luu; Douglas Young; Howard Cooper; Neil E Reiner
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

8.  Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro.

Authors:  F A Post; C Manca; O Neyrolles; B Ryffel; D B Young; G Kaplan
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 9.  Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis.

Authors:  P J Brennan
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

10.  Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.

Authors:  Rish K Pai; Marilyn Convery; Thomas A Hamilton; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

View more
  15 in total

1.  The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes.

Authors:  Saet-Byel Jung; Chul-Su Yang; Ji-Sook Lee; A-Rum Shin; Sung-Soo Jung; Ji Woong Son; Clifford V Harding; Hwa-Jung Kim; Jeong-Kyu Park; Tae-Hyun Paik; Chang-Hwa Song; Eun-Kyeong Jo
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 2.  Lipoproteins of bacterial pathogens.

Authors:  A Kovacs-Simon; R W Titball; S L Michell
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Mycobacterium tuberculosis lipoprotein-induced association of TLR2 with protein kinase C zeta in lipid rafts contributes to reactive oxygen species-dependent inflammatory signalling in macrophages.

Authors:  Dong-Min Shin; Chul-Su Yang; Ji-Yeon Lee; Sung Joong Lee; Hong-Hee Choi; Hye-Mi Lee; Jae-Min Yuk; Clifford V Harding; Eun-Kyeong Jo
Journal:  Cell Microbiol       Date:  2008-07-15       Impact factor: 3.715

4.  RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins.

Authors:  Antje Blumenthal; Toshihiko Kobayashi; Lynda M Pierini; Niaz Banaei; Joel D Ernst; Kensuke Miyake; Sabine Ehrt
Journal:  Cell Host Microbe       Date:  2009-01-22       Impact factor: 21.023

5.  The Delta fbpA mutant derived from Mycobacterium tuberculosis H37Rv has an enhanced susceptibility to intracellular antimicrobial oxidative mechanisms, undergoes limited phagosome maturation and activates macrophages and dendritic cells.

Authors:  Muralidhar K Katti; Guixiang Dai; Lisa Y Armitige; Carlos Rivera Marrero; Sundarsingh Daniel; Christopher R Singh; Devin R Lindsey; Subramanian Dhandayuthapani; Robert L Hunter; Chinnaswamy Jagannath
Journal:  Cell Microbiol       Date:  2008-01-31       Impact factor: 3.715

6.  The presence of a galactosamine substituent on the arabinogalactan of Mycobacterium tuberculosis abrogates full maturation of human peripheral blood monocyte-derived dendritic cells and increases secretion of IL-10.

Authors:  William H Wheat; Rabeb Dhouib; Shiva K Angala; Gérald Larrouy-Maumus; Karen Dobos; Jérôme Nigou; John S Spencer; Mary Jackson
Journal:  Tuberculosis (Edinb)       Date:  2015-05-14       Impact factor: 3.131

7.  Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages.

Authors:  Damien Portevin; Sébastien Gagneux; Iñaki Comas; Douglas Young
Journal:  PLoS Pathog       Date:  2011-03-03       Impact factor: 6.823

8.  Genetic determination of the effect of post-translational modification on the innate immune response to the 19 kDa lipoprotein of Mycobacterium tuberculosis.

Authors:  Katalin A Wilkinson; Sandra M Newton; Graham R Stewart; Adrian R Martineau; Janisha Patel; Susan M Sullivan; Jean-Louis Herrmann; Olivier Neyrolles; Douglas B Young; Robert J Wilkinson
Journal:  BMC Microbiol       Date:  2009-05-14       Impact factor: 3.605

9.  A mutant of Mycobacterium tuberculosis lacking the 19-kDa lipoprotein Rv3763 is highly attenuated in vivo but retains potent vaccinogenic properties.

Authors:  Marcela Henao-Tamayo; Ana Paula Junqueira-Kipnis; Diane Ordway; Mercedes Gonzales-Juarrero; Graham R Stewart; Douglas B Young; Robert J Wilkinson; Randall J Basaraba; Ian M Orme
Journal:  Vaccine       Date:  2007-08-13       Impact factor: 3.641

Review 10.  Exosome function: from tumor immunology to pathogen biology.

Authors:  Jeffrey S Schorey; Sanchita Bhatnagar
Journal:  Traffic       Date:  2008-03-06       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.